These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8682137)

  • 1. Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease.
    Lefkovits J; Topol EJ
    Eur Heart J; 1996 Jan; 17(1):9-18. PubMed ID: 8682137
    [No Abstract]   [Full Text] [Related]  

  • 2. Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor.
    Ohman EM; Harrington RA; Lincoff AM; Kitt MM; Kleiman NS; Tcheng JE
    Eur Heart J; 1995 Nov; 16 Suppl L():50-5. PubMed ID: 8869019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CardioPulse: Platelet inhibitors and their differences.
    Gurbel PA; Tantry US
    Eur Heart J; 2016 Jan; 37(4):323-6. PubMed ID: 26795932
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Maree A; Fitzgerald D
    Haematologica; 2001 Nov; 86(11 Suppl 2):45-8. PubMed ID: 11926777
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction.
    Holmes MB; Sobel BE; Cannon CP; Schneider DJ
    Am J Cardiol; 2000 Feb; 85(4):491-3, A10. PubMed ID: 10728957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet glycoprotein IIb/IIIa antagonists: pharmacology and clinical developments.
    Kam PC; Egan MK
    Anesthesiology; 2002 May; 96(5):1237-49. PubMed ID: 11981166
    [No Abstract]   [Full Text] [Related]  

  • 7. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
    Ferguson JJ; Waly HM; Wilson JM
    Am Heart J; 1998 Apr; 135(4):S35-42. PubMed ID: 9539494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
    Konstantopoulos K; Mousa SA
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1086-92. PubMed ID: 11892918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study).
    Tamberella MR; Bhatt DL; Chew DP; Kereiakes DJ; Topol EJ; Steinhubl SR;
    Am J Cardiol; 2002 Jun; 89(12):1429-31. PubMed ID: 12062743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
    Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
    Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical impact of platelet glycoprotein IIb/IIIa receptor blockade in cardiovascular medicine.
    Mak KH; Tan AT; Chan C; Koh TH; Topol EJ
    Jpn Circ J; 1998 Apr; 62(4):233-43. PubMed ID: 9583455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein IIb/IIIa integrin blockade.
    Madan M; Berkowitz SD; Tcheng JE
    Circulation; 1998 Dec; 98(23):2629-35. PubMed ID: 9843473
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?
    Quinn MJ; Plow EF; Topol EJ
    Circulation; 2002 Jul; 106(3):379-85. PubMed ID: 12119257
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet glycoprotein IIb/IIIa inhibitors: overview and implications for the anesthesiologist.
    Chun R; Orser BA; Madan M
    Anesth Analg; 2002 Oct; 95(4):879-88. PubMed ID: 12351262
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions.
    Phillips DR; Law D; Scarborough RM
    Arch Pathol Lab Med; 1998 Sep; 122(9):811-2. PubMed ID: 9740139
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycoprotein IIb/IIIa platelet receptor blockers: are they ready for prime time in patients with unstable coronary artery disease?
    Conti CR
    Clin Cardiol; 1999 Feb; 22(2):57-8. PubMed ID: 10068840
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monitoring of tienopyridines or glycoprotein IIb/IIIa-receptor antagonists: simple platelet function tests].
    Halbmayer WM
    Hamostaseologie; 2004 Aug; 24(3):203-6. PubMed ID: 15314706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseases.
    Chong PH
    Am J Health Syst Pharm; 1998 Nov; 55(22):2363-86. PubMed ID: 9825033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging.
    Sebastian M; Makkar R
    Drugs Aging; 1999 Sep; 15(3):207-18. PubMed ID: 10503813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.